| Serial Number | 76113583 |
| Word Mark | DESADENOSINE |
| Filing Date | Wednesday, August 16, 2000 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Saturday, August 15, 2009 |
| Registration Number | 2670996 |
| Registration Date | Tuesday, January 7, 2003 |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 15, 2002 |
| Goods and Services | Describing and providing medical diagnostic and pharmaceutical preparations with nucleotide sequences that have a low content of, or fully lack, adenosine, for testing, preventing, and therapeutically treating human and non-human animal respiratory ailments that may be associated with hyper-sensitivity or hyper-responsiveness to adenosine, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in many cases are adenosine receptor associated symptoms; pharmaceutical preparations for the treatment of airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vascoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, hepatic metastases, etc., as well as all other metastatic cancers, e.g., cancers which metastasized to the lung(s), breast, liver and prostate |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Saturday, August 15, 2009 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, August 31, 1995 |
| First Use In Commerce Date | Thursday, November 30, 1995 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Party Name | EPIGENESIS Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cranbury, NJ 08512 |
| Event Date | Event Description |
| Saturday, August 15, 2009 | CANCELLED SEC. 8 (6-YR) |
| Thursday, January 17, 2008 | CASE FILE IN TICRS |
| Tuesday, January 7, 2003 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 15, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 25, 2002 | NOTICE OF PUBLICATION |
| Tuesday, March 5, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, September 27, 2001 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, March 22, 2001 | NON-FINAL ACTION MAILED |
| Wednesday, March 14, 2001 | ASSIGNED TO EXAMINER |
| Friday, February 16, 2001 | ASSIGNED TO EXAMINER |